2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Venipuncture: new trials by email Literature Review of Venipuncture trials Research Report on Venipuncture
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation Polyclonal Regulatory T Cells, Everolimus, Tacrolimus - Kidney Transplant, Adult Living Donor Kidney Transplant Recipients | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 32 | 2016-09-20 | 2026-09-24 |
| Phase I/II Thymus Transplantation With Immunosuppression #950 Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Switzerland GmbH | 14 | 2005-12-19 | 2022-03-25 |
DiGeorge Syndrome (1) · Hypocalcemia (1) · Hypoparathyroidism (1) · Immunologic Deficiency Syndromes (1) · Thymic aplasia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sumitomo Pharma Switzerland GmbH (1)
United States (2)
Flavio Vincenti, MD (1) · M. Louise Markert, MD, PhD (1) · Sindhu Chandran, MD (1)
PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606
K12HD043494 (1), R01AI047040 (1), R01AI054843 (1)